Vitruvias Therapeutics thyroid tablet recall: The US Food and Drug Administration has recalled a thyroid medication over possibility that it’s “superpotent.” The thyroid medicine recall involving Vitruvias Therapeutics has been classified as a 'Class I recall', the most serious recall category. The FDA recall concerns one lot of Thyroid Tablets, USP 30 mg that may be “superpotent,” meaning the tablets could contain more thyroid hormone than intended.
The recall was first announced by Vitruvias Therapeutics in August. Now, the FDA has upgraded the seriousness of the recall for this brand of thyroid medication after the manufacturer ceased operations. A Class I recall means there is a reasonable probability that using or being exposed to the recalled product could cause serious health consequences or death.
